NEW YORK (GenomeWeb News) – Mitsubishi Chemical Safety Institute has become the first Illumina certified genetic analysis service provider in Japan, Illumina announced today.
The Mitsubishi Chemical Safety Institute provides various analyses and services for pharmaceutical and chemical companies as well as for public institutions. It also offers whole-genome and targeted genotyping services using Illumina’s Infinium and GoldenGate assays.
Because of its involvement in toxicogenomic and pharmacogenomic investigations, MCSI “has acquired an abundance of experience in the development of genomic analysis technologies,” said Masaru Sekijima, general manager of the Advanced Medical Science Research Center at MCSI.
Companies participating in Illumina’s certified service provider program are required to undergo a certification process based on data generation and data certification in addition to an on-site facility and process audit.